Altrubio Inc.
Clinical trials sponsored by Altrubio Inc., explained in plain language.
-
New hope for tough colitis cases: experimental drug enters mid-stage trial
Disease control OngoingThis study tests an experimental drug called ALTB-268 in 50 adults with moderate-to-severe ulcerative colitis that did not improve with biologic therapies. The goal is to see if the drug can reduce disease activity, measured by a standard score. Participants receive the drug open…
Phase: PHASE2 • Sponsor: AltruBio Inc. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New UC drug candidate ALTB-268 begins first human safety tests
Knowledge-focused OngoingThis study is an early test of a new drug called ALTB-268, which may one day treat ulcerative colitis. It involves 24 healthy adults who receive a single dose of the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to make sure the …
Phase: PHASE1 • Sponsor: AltruBio Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 02:38 UTC